nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—ABCC2—Sulfasalazine—Crohn's disease	0.107	0.354	CbGbCtD
Docetaxel—ABCG2—Sulfasalazine—Crohn's disease	0.0968	0.32	CbGbCtD
Docetaxel—CYP3A5—Sulfasalazine—Crohn's disease	0.0537	0.178	CbGbCtD
Docetaxel—ABCB1—Prednisone—Crohn's disease	0.0279	0.0924	CbGbCtD
Docetaxel—CYP3A4—Prednisone—Crohn's disease	0.0167	0.0553	CbGbCtD
Docetaxel—ABCC2—bile—Crohn's disease	0.0112	0.0708	CbGeAlD
Docetaxel—KIF11—mammalian vulva—Crohn's disease	0.00789	0.0498	CbGeAlD
Docetaxel—BCL2—mouth—Crohn's disease	0.00656	0.0414	CbGeAlD
Docetaxel—NR1I2—digestive system—Crohn's disease	0.00488	0.0308	CbGeAlD
Docetaxel—MAP4—skin of body—Crohn's disease	0.00399	0.0252	CbGeAlD
Docetaxel—KIF11—lymph node—Crohn's disease	0.00395	0.025	CbGeAlD
Docetaxel—BCL2—epithelium—Crohn's disease	0.00381	0.0241	CbGeAlD
Docetaxel—BCL2—smooth muscle tissue—Crohn's disease	0.00367	0.0232	CbGeAlD
Docetaxel—BCL2—skin of body—Crohn's disease	0.00363	0.0229	CbGeAlD
Docetaxel—EGFR—mammalian vulva—Crohn's disease	0.00327	0.0206	CbGeAlD
Docetaxel—MAP4—lymphoid tissue—Crohn's disease	0.00323	0.0204	CbGeAlD
Docetaxel—TUBB3—lymphoid tissue—Crohn's disease	0.00323	0.0204	CbGeAlD
Docetaxel—TUBB3—digestive system—Crohn's disease	0.00319	0.0201	CbGeAlD
Docetaxel—MAP4—digestive system—Crohn's disease	0.00319	0.0201	CbGeAlD
Docetaxel—BCL2—lymphoid tissue—Crohn's disease	0.00294	0.0185	CbGeAlD
Docetaxel—BCL2—digestive system—Crohn's disease	0.0029	0.0183	CbGeAlD
Docetaxel—MAP2—mammalian vulva—Crohn's disease	0.00287	0.0181	CbGeAlD
Docetaxel—MAP2—digestive system—Crohn's disease	0.00251	0.0159	CbGeAlD
Docetaxel—TUBB4A—skin of body—Crohn's disease	0.00243	0.0153	CbGeAlD
Docetaxel—MAPT—lymph node—Crohn's disease	0.00232	0.0146	CbGeAlD
Docetaxel—TUBB6—epithelium—Crohn's disease	0.00229	0.0145	CbGeAlD
Docetaxel—TUBB—smooth muscle tissue—Crohn's disease	0.00225	0.0142	CbGeAlD
Docetaxel—TUBB2A—smooth muscle tissue—Crohn's disease	0.00224	0.0141	CbGeAlD
Docetaxel—TUBB2A—skin of body—Crohn's disease	0.00221	0.0139	CbGeAlD
Docetaxel—TUBB6—smooth muscle tissue—Crohn's disease	0.00221	0.0139	CbGeAlD
Docetaxel—TUBB6—skin of body—Crohn's disease	0.00218	0.0138	CbGeAlD
Docetaxel—SLC22A7—digestive system—Crohn's disease	0.00217	0.0137	CbGeAlD
Docetaxel—TUBB2B—mammalian vulva—Crohn's disease	0.00214	0.0135	CbGeAlD
Docetaxel—TUBB—mammalian vulva—Crohn's disease	0.00203	0.0128	CbGeAlD
Docetaxel—TUBB2A—mammalian vulva—Crohn's disease	0.00201	0.0127	CbGeAlD
Docetaxel—TUBB6—mammalian vulva—Crohn's disease	0.00199	0.0125	CbGeAlD
Docetaxel—TUBB4A—lymphoid tissue—Crohn's disease	0.00197	0.0124	CbGeAlD
Docetaxel—TUBB4A—digestive system—Crohn's disease	0.00194	0.0123	CbGeAlD
Docetaxel—TUBB4B—smooth muscle tissue—Crohn's disease	0.00192	0.0121	CbGeAlD
Docetaxel—TUBB4B—skin of body—Crohn's disease	0.00189	0.012	CbGeAlD
Docetaxel—TUBB2B—digestive system—Crohn's disease	0.00188	0.0118	CbGeAlD
Docetaxel—MAP4—lymph node—Crohn's disease	0.00182	0.0115	CbGeAlD
Docetaxel—TUBB2A—digestive system—Crohn's disease	0.00177	0.0112	CbGeAlD
Docetaxel—TUBB6—lymphoid tissue—Crohn's disease	0.00176	0.0111	CbGeAlD
Docetaxel—TUBB6—digestive system—Crohn's disease	0.00174	0.011	CbGeAlD
Docetaxel—ABCC10—mammalian vulva—Crohn's disease	0.00174	0.011	CbGeAlD
Docetaxel—TUBB4B—mammalian vulva—Crohn's disease	0.00173	0.0109	CbGeAlD
Docetaxel—BCL2—lymph node—Crohn's disease	0.00166	0.0105	CbGeAlD
Docetaxel—EGFR—lymph node—Crohn's disease	0.00164	0.0103	CbGeAlD
Docetaxel—ABCC10—lymphoid tissue—Crohn's disease	0.00154	0.00975	CbGeAlD
Docetaxel—TUBB4B—lymphoid tissue—Crohn's disease	0.00153	0.00968	CbGeAlD
Docetaxel—ABCC10—digestive system—Crohn's disease	0.00153	0.00963	CbGeAlD
Docetaxel—CYP1B1—smooth muscle tissue—Crohn's disease	0.00152	0.00959	CbGeAlD
Docetaxel—TUBB4B—digestive system—Crohn's disease	0.00151	0.00956	CbGeAlD
Docetaxel—CYP1B1—skin of body—Crohn's disease	0.0015	0.00947	CbGeAlD
Docetaxel—MAP2—lymph node—Crohn's disease	0.00144	0.00906	CbGeAlD
Docetaxel—Neoplasm—Azathioprine—Crohn's disease	0.00135	0.00414	CcSEcCtD
Docetaxel—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00132	0.00406	CcSEcCtD
Docetaxel—Influenza like illness—Mesalazine—Crohn's disease	0.00132	0.00405	CcSEcCtD
Docetaxel—Colitis—Mesalazine—Crohn's disease	0.0013	0.004	CcSEcCtD
Docetaxel—Menstruation irregular—Prednisone—Crohn's disease	0.0013	0.00398	CcSEcCtD
Docetaxel—Candida infection—Mesalazine—Crohn's disease	0.0013	0.00398	CcSEcCtD
Docetaxel—Skin exfoliation—Mesalazine—Crohn's disease	0.0013	0.00398	CcSEcCtD
Docetaxel—Neuropathy—Mesalazine—Crohn's disease	0.00127	0.00391	CcSEcCtD
Docetaxel—ABCC1—mammalian vulva—Crohn's disease	0.00123	0.00777	CbGeAlD
Docetaxel—ABCC2—digestive system—Crohn's disease	0.00123	0.00773	CbGeAlD
Docetaxel—CYP1B1—lymphoid tissue—Crohn's disease	0.00121	0.00767	CbGeAlD
Docetaxel—Hepatic failure—Azathioprine—Crohn's disease	0.0012	0.0037	CcSEcCtD
Docetaxel—CYP1B1—digestive system—Crohn's disease	0.0012	0.00757	CbGeAlD
Docetaxel—Febrile neutropenia—Prednisone—Crohn's disease	0.00119	0.00367	CcSEcCtD
Docetaxel—Immune system disorder—Mercaptopurine—Crohn's disease	0.00113	0.00348	CcSEcCtD
Docetaxel—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00113	0.00348	CcSEcCtD
Docetaxel—Embolism—Prednisone—Crohn's disease	0.00112	0.00344	CcSEcCtD
Docetaxel—Alopecia—Mercaptopurine—Crohn's disease	0.00111	0.00341	CcSEcCtD
Docetaxel—TUBB4A—lymph node—Crohn's disease	0.00111	0.007	CbGeAlD
Docetaxel—Deafness—Mesalazine—Crohn's disease	0.0011	0.00338	CcSEcCtD
Docetaxel—Hepatic failure—Mesalazine—Crohn's disease	0.0011	0.00337	CcSEcCtD
Docetaxel—Malnutrition—Mercaptopurine—Crohn's disease	0.00109	0.00336	CcSEcCtD
Docetaxel—TUBB2B—lymph node—Crohn's disease	0.00107	0.00677	CbGeAlD
Docetaxel—Atrial fibrillation—Mesalazine—Crohn's disease	0.00104	0.00319	CcSEcCtD
Docetaxel—Renal impairment—Mesalazine—Crohn's disease	0.00103	0.00318	CcSEcCtD
Docetaxel—Dermatitis bullous—Mesalazine—Crohn's disease	0.00103	0.00317	CcSEcCtD
Docetaxel—ABCG2—mammalian vulva—Crohn's disease	0.00102	0.00643	CbGeAlD
Docetaxel—TUBB—lymph node—Crohn's disease	0.00101	0.0064	CbGeAlD
Docetaxel—Anaemia—Mercaptopurine—Crohn's disease	0.00101	0.0031	CcSEcCtD
Docetaxel—TUBB2A—lymph node—Crohn's disease	0.00101	0.00637	CbGeAlD
Docetaxel—Lethargy—Mesalazine—Crohn's disease	0.00101	0.00309	CcSEcCtD
Docetaxel—TUBB6—lymph node—Crohn's disease	0.000995	0.00628	CbGeAlD
Docetaxel—Gastrointestinal haemorrhage—Mesalazine—Crohn's disease	0.000985	0.00303	CcSEcCtD
Docetaxel—Leukopenia—Mercaptopurine—Crohn's disease	0.000978	0.00301	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000974	0.00299	CcSEcCtD
Docetaxel—Dermatitis atopic—Prednisone—Crohn's disease	0.00097	0.00298	CcSEcCtD
Docetaxel—Migraine—Mesalazine—Crohn's disease	0.000969	0.00298	CcSEcCtD
Docetaxel—Neuritis—Prednisone—Crohn's disease	0.000962	0.00295	CcSEcCtD
Docetaxel—Arthralgia—Mercaptopurine—Crohn's disease	0.00093	0.00286	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000924	0.00284	CcSEcCtD
Docetaxel—Necrosis—Prednisone—Crohn's disease	0.000915	0.00281	CcSEcCtD
Docetaxel—Liver function test abnormal—Mesalazine—Crohn's disease	0.000909	0.00279	CcSEcCtD
Docetaxel—Dry skin—Mesalazine—Crohn's disease	0.000903	0.00277	CcSEcCtD
Docetaxel—Abdominal pain upper—Mesalazine—Crohn's disease	0.0009	0.00276	CcSEcCtD
Docetaxel—Orthostatic hypotension—Mesalazine—Crohn's disease	0.0009	0.00276	CcSEcCtD
Docetaxel—Oedema—Mercaptopurine—Crohn's disease	0.000892	0.00274	CcSEcCtD
Docetaxel—Breast disorder—Mesalazine—Crohn's disease	0.00089	0.00273	CcSEcCtD
Docetaxel—Pancytopenia—Azathioprine—Crohn's disease	0.000887	0.00273	CcSEcCtD
Docetaxel—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.000887	0.00272	CcSEcCtD
Docetaxel—Cramp muscle—Mesalazine—Crohn's disease	0.000887	0.00272	CcSEcCtD
Docetaxel—Nasopharyngitis—Mesalazine—Crohn's disease	0.000881	0.00271	CcSEcCtD
Docetaxel—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000873	0.00268	CcSEcCtD
Docetaxel—ABCC10—lymph node—Crohn's disease	0.000872	0.0055	CbGeAlD
Docetaxel—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000869	0.00267	CcSEcCtD
Docetaxel—Skin disorder—Mercaptopurine—Crohn's disease	0.000866	0.00266	CcSEcCtD
Docetaxel—TUBB4B—lymph node—Crohn's disease	0.000865	0.00546	CbGeAlD
Docetaxel—Dysphagia—Mesalazine—Crohn's disease	0.000851	0.00262	CcSEcCtD
Docetaxel—Anorexia—Mercaptopurine—Crohn's disease	0.00085	0.00261	CcSEcCtD
Docetaxel—Pneumonia—Azathioprine—Crohn's disease	0.000838	0.00257	CcSEcCtD
Docetaxel—Bronchospasm—Mesalazine—Crohn's disease	0.000837	0.00257	CcSEcCtD
Docetaxel—Infestation NOS—Azathioprine—Crohn's disease	0.000833	0.00256	CcSEcCtD
Docetaxel—Infestation—Azathioprine—Crohn's disease	0.000833	0.00256	CcSEcCtD
Docetaxel—CYP3A5—digestive system—Crohn's disease	0.000829	0.00523	CbGeAlD
Docetaxel—Angina pectoris—Mesalazine—Crohn's disease	0.000829	0.00255	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000826	0.00254	CcSEcCtD
Docetaxel—Amenorrhoea—Prednisone—Crohn's disease	0.000817	0.00251	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000813	0.0025	CcSEcCtD
Docetaxel—Pancytopenia—Mesalazine—Crohn's disease	0.000808	0.00248	CcSEcCtD
Docetaxel—Neutropenia—Mesalazine—Crohn's disease	0.000796	0.00245	CcSEcCtD
Docetaxel—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000788	0.00242	CcSEcCtD
Docetaxel—Agranulocytosis—Azathioprine—Crohn's disease	0.000778	0.00239	CcSEcCtD
Docetaxel—Decreased appetite—Mercaptopurine—Crohn's disease	0.000775	0.00238	CcSEcCtD
Docetaxel—Weight increased—Mesalazine—Crohn's disease	0.000775	0.00238	CcSEcCtD
Docetaxel—Weight decreased—Mesalazine—Crohn's disease	0.00077	0.00237	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00077	0.00237	CcSEcCtD
Docetaxel—Pneumonia—Mesalazine—Crohn's disease	0.000763	0.00235	CcSEcCtD
Docetaxel—Infestation NOS—Mesalazine—Crohn's disease	0.000759	0.00233	CcSEcCtD
Docetaxel—Infestation—Mesalazine—Crohn's disease	0.000759	0.00233	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000752	0.00231	CcSEcCtD
Docetaxel—Haemoglobin—Azathioprine—Crohn's disease	0.000752	0.00231	CcSEcCtD
Docetaxel—Haemorrhage—Azathioprine—Crohn's disease	0.000748	0.0023	CcSEcCtD
Docetaxel—Renal failure—Mesalazine—Crohn's disease	0.000746	0.00229	CcSEcCtD
Docetaxel—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000744	0.00229	CcSEcCtD
Docetaxel—Jaundice—Mesalazine—Crohn's disease	0.00074	0.00227	CcSEcCtD
Docetaxel—Stomatitis—Mesalazine—Crohn's disease	0.00074	0.00227	CcSEcCtD
Docetaxel—Conjunctivitis—Mesalazine—Crohn's disease	0.000738	0.00227	CcSEcCtD
Docetaxel—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000718	0.00221	CcSEcCtD
Docetaxel—Epistaxis—Mesalazine—Crohn's disease	0.000716	0.0022	CcSEcCtD
Docetaxel—Agranulocytosis—Mesalazine—Crohn's disease	0.000708	0.00218	CcSEcCtD
Docetaxel—Erythema multiforme—Azathioprine—Crohn's disease	0.000707	0.00217	CcSEcCtD
Docetaxel—Body temperature increased—Mercaptopurine—Crohn's disease	0.000705	0.00217	CcSEcCtD
Docetaxel—ABCC2—lymph node—Crohn's disease	0.0007	0.00442	CbGeAlD
Docetaxel—Skin exfoliation—Prednisone—Crohn's disease	0.000685	0.00211	CcSEcCtD
Docetaxel—CYP1B1—lymph node—Crohn's disease	0.000685	0.00433	CbGeAlD
Docetaxel—Haemoglobin—Mesalazine—Crohn's disease	0.000685	0.0021	CcSEcCtD
Docetaxel—Rhinitis—Mesalazine—Crohn's disease	0.000683	0.0021	CcSEcCtD
Docetaxel—Fluid retention—Prednisone—Crohn's disease	0.000682	0.00209	CcSEcCtD
Docetaxel—Hepatitis—Mesalazine—Crohn's disease	0.000681	0.00209	CcSEcCtD
Docetaxel—Haemorrhage—Mesalazine—Crohn's disease	0.000681	0.00209	CcSEcCtD
Docetaxel—Pharyngitis—Mesalazine—Crohn's disease	0.000676	0.00208	CcSEcCtD
Docetaxel—Immune system disorder—Azathioprine—Crohn's disease	0.000676	0.00208	CcSEcCtD
Docetaxel—Mediastinal disorder—Azathioprine—Crohn's disease	0.000674	0.00207	CcSEcCtD
Docetaxel—Neuropathy—Prednisone—Crohn's disease	0.000674	0.00207	CcSEcCtD
Docetaxel—Urinary tract disorder—Mesalazine—Crohn's disease	0.000673	0.00207	CcSEcCtD
Docetaxel—Oedema peripheral—Mesalazine—Crohn's disease	0.000671	0.00206	CcSEcCtD
Docetaxel—Chills—Azathioprine—Crohn's disease	0.000671	0.00206	CcSEcCtD
Docetaxel—Connective tissue disorder—Mesalazine—Crohn's disease	0.00067	0.00206	CcSEcCtD
Docetaxel—Arrhythmia—Azathioprine—Crohn's disease	0.000668	0.00205	CcSEcCtD
Docetaxel—Urethral disorder—Mesalazine—Crohn's disease	0.000668	0.00205	CcSEcCtD
Docetaxel—Alopecia—Azathioprine—Crohn's disease	0.000661	0.00203	CcSEcCtD
Docetaxel—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000657	0.00202	CcSEcCtD
Docetaxel—Oesophagitis—Prednisone—Crohn's disease	0.000656	0.00202	CcSEcCtD
Docetaxel—Erythema multiforme—Mesalazine—Crohn's disease	0.000644	0.00198	CcSEcCtD
Docetaxel—Pulmonary oedema—Prednisone—Crohn's disease	0.000639	0.00196	CcSEcCtD
Docetaxel—Eye disorder—Mesalazine—Crohn's disease	0.000637	0.00196	CcSEcCtD
Docetaxel—Cardiac disorder—Mesalazine—Crohn's disease	0.000632	0.00194	CcSEcCtD
Docetaxel—Sepsis—Prednisone—Crohn's disease	0.000623	0.00191	CcSEcCtD
Docetaxel—CYP3A4—digestive system—Crohn's disease	0.000622	0.00393	CbGeAlD
Docetaxel—Angiopathy—Mesalazine—Crohn's disease	0.000618	0.0019	CcSEcCtD
Docetaxel—ABCC1—lymph node—Crohn's disease	0.000616	0.00389	CbGeAlD
Docetaxel—Immune system disorder—Mesalazine—Crohn's disease	0.000615	0.00189	CcSEcCtD
Docetaxel—Mediastinal disorder—Mesalazine—Crohn's disease	0.000614	0.00189	CcSEcCtD
Docetaxel—Chills—Mesalazine—Crohn's disease	0.000611	0.00188	CcSEcCtD
Docetaxel—Diarrhoea—Mercaptopurine—Crohn's disease	0.00061	0.00187	CcSEcCtD
Docetaxel—Alopecia—Mesalazine—Crohn's disease	0.000602	0.00185	CcSEcCtD
Docetaxel—Thrombophlebitis—Prednisone—Crohn's disease	0.000602	0.00185	CcSEcCtD
Docetaxel—Anaemia—Azathioprine—Crohn's disease	0.000602	0.00185	CcSEcCtD
Docetaxel—Mental disorder—Mesalazine—Crohn's disease	0.000597	0.00183	CcSEcCtD
Docetaxel—Erythema—Mesalazine—Crohn's disease	0.000593	0.00182	CcSEcCtD
Docetaxel—Leukopenia—Azathioprine—Crohn's disease	0.000583	0.00179	CcSEcCtD
Docetaxel—Dysgeusia—Mesalazine—Crohn's disease	0.000581	0.00178	CcSEcCtD
Docetaxel—ABCB1—epithelium—Crohn's disease	0.000579	0.00366	CbGeAlD
Docetaxel—Cardiac failure congestive—Prednisone—Crohn's disease	0.000575	0.00177	CcSEcCtD
Docetaxel—Back pain—Mesalazine—Crohn's disease	0.000574	0.00176	CcSEcCtD
Docetaxel—Muscle spasms—Mesalazine—Crohn's disease	0.00057	0.00175	CcSEcCtD
Docetaxel—Vomiting—Mercaptopurine—Crohn's disease	0.000567	0.00174	CcSEcCtD
Docetaxel—Rash—Mercaptopurine—Crohn's disease	0.000562	0.00173	CcSEcCtD
Docetaxel—Dermatitis—Mercaptopurine—Crohn's disease	0.000562	0.00173	CcSEcCtD
Docetaxel—Arthralgia—Azathioprine—Crohn's disease	0.000554	0.0017	CcSEcCtD
Docetaxel—Myalgia—Azathioprine—Crohn's disease	0.000554	0.0017	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000551	0.00169	CcSEcCtD
Docetaxel—Anaemia—Mesalazine—Crohn's disease	0.000548	0.00168	CcSEcCtD
Docetaxel—Cardiac failure—Prednisone—Crohn's disease	0.000534	0.00164	CcSEcCtD
Docetaxel—Syncope—Mesalazine—Crohn's disease	0.000532	0.00163	CcSEcCtD
Docetaxel—Lethargy—Prednisone—Crohn's disease	0.000532	0.00163	CcSEcCtD
Docetaxel—Leukopenia—Mesalazine—Crohn's disease	0.000531	0.00163	CcSEcCtD
Docetaxel—Nausea—Mercaptopurine—Crohn's disease	0.00053	0.00163	CcSEcCtD
Docetaxel—Infection—Azathioprine—Crohn's disease	0.000528	0.00162	CcSEcCtD
Docetaxel—Palpitations—Mesalazine—Crohn's disease	0.000524	0.00161	CcSEcCtD
Docetaxel—Loss of consciousness—Mesalazine—Crohn's disease	0.000521	0.0016	CcSEcCtD
Docetaxel—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000521	0.0016	CcSEcCtD
Docetaxel—Thrombocytopenia—Azathioprine—Crohn's disease	0.00052	0.0016	CcSEcCtD
Docetaxel—Cough—Mesalazine—Crohn's disease	0.000518	0.00159	CcSEcCtD
Docetaxel—Skin disorder—Azathioprine—Crohn's disease	0.000516	0.00159	CcSEcCtD
Docetaxel—Hypertension—Mesalazine—Crohn's disease	0.000512	0.00157	CcSEcCtD
Docetaxel—ABCG2—lymph node—Crohn's disease	0.00051	0.00322	CbGeAlD
Docetaxel—Myalgia—Mesalazine—Crohn's disease	0.000505	0.00155	CcSEcCtD
Docetaxel—Chest pain—Mesalazine—Crohn's disease	0.000505	0.00155	CcSEcCtD
Docetaxel—Arthralgia—Mesalazine—Crohn's disease	0.000505	0.00155	CcSEcCtD
Docetaxel—ABCB1—mammalian vulva—Crohn's disease	0.000502	0.00317	CbGeAlD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000501	0.00154	CcSEcCtD
Docetaxel—Hypotension—Azathioprine—Crohn's disease	0.000497	0.00153	CcSEcCtD
Docetaxel—Dry mouth—Mesalazine—Crohn's disease	0.000494	0.00152	CcSEcCtD
Docetaxel—Confusional state—Mesalazine—Crohn's disease	0.000488	0.0015	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000484	0.00149	CcSEcCtD
Docetaxel—Anaphylactic shock—Mesalazine—Crohn's disease	0.000484	0.00149	CcSEcCtD
Docetaxel—Oedema—Mesalazine—Crohn's disease	0.000484	0.00149	CcSEcCtD
Docetaxel—Infection—Mesalazine—Crohn's disease	0.000481	0.00148	CcSEcCtD
Docetaxel—Dry skin—Prednisone—Crohn's disease	0.000478	0.00147	CcSEcCtD
Docetaxel—Shock—Mesalazine—Crohn's disease	0.000476	0.00146	CcSEcCtD
Docetaxel—Nervous system disorder—Mesalazine—Crohn's disease	0.000475	0.00146	CcSEcCtD
Docetaxel—Thrombocytopenia—Mesalazine—Crohn's disease	0.000474	0.00146	CcSEcCtD
Docetaxel—Tachycardia—Mesalazine—Crohn's disease	0.000472	0.00145	CcSEcCtD
Docetaxel—Skin disorder—Mesalazine—Crohn's disease	0.00047	0.00144	CcSEcCtD
Docetaxel—Anorexia—Mesalazine—Crohn's disease	0.000461	0.00142	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00046	0.00141	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000459	0.00141	CcSEcCtD
Docetaxel—Hypotension—Mesalazine—Crohn's disease	0.000452	0.00139	CcSEcCtD
Docetaxel—ABCB1—lymphoid tissue—Crohn's disease	0.000446	0.00282	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000441	0.00136	CcSEcCtD
Docetaxel—ABCB1—digestive system—Crohn's disease	0.000441	0.00278	CbGeAlD
Docetaxel—Feeling abnormal—Azathioprine—Crohn's disease	0.000438	0.00135	CcSEcCtD
Docetaxel—Insomnia—Mesalazine—Crohn's disease	0.000438	0.00135	CcSEcCtD
Docetaxel—Paraesthesia—Mesalazine—Crohn's disease	0.000435	0.00134	CcSEcCtD
Docetaxel—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000435	0.00134	CcSEcCtD
Docetaxel—Dyspnoea—Mesalazine—Crohn's disease	0.000432	0.00133	CcSEcCtD
Docetaxel—Somnolence—Mesalazine—Crohn's disease	0.00043	0.00132	CcSEcCtD
Docetaxel—Dyspepsia—Mesalazine—Crohn's disease	0.000426	0.00131	CcSEcCtD
Docetaxel—Neutropenia—Prednisone—Crohn's disease	0.000421	0.00129	CcSEcCtD
Docetaxel—Decreased appetite—Mesalazine—Crohn's disease	0.000421	0.00129	CcSEcCtD
Docetaxel—Abdominal pain—Azathioprine—Crohn's disease	0.00042	0.00129	CcSEcCtD
Docetaxel—Body temperature increased—Azathioprine—Crohn's disease	0.00042	0.00129	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000418	0.00128	CcSEcCtD
Docetaxel—Fatigue—Mesalazine—Crohn's disease	0.000417	0.00128	CcSEcCtD
Docetaxel—Pain—Mesalazine—Crohn's disease	0.000414	0.00127	CcSEcCtD
Docetaxel—Constipation—Mesalazine—Crohn's disease	0.000414	0.00127	CcSEcCtD
Docetaxel—Weight increased—Prednisone—Crohn's disease	0.00041	0.00126	CcSEcCtD
Docetaxel—Weight decreased—Prednisone—Crohn's disease	0.000407	0.00125	CcSEcCtD
Docetaxel—Feeling abnormal—Mesalazine—Crohn's disease	0.000399	0.00123	CcSEcCtD
Docetaxel—Acute coronary syndrome—Prednisone—Crohn's disease	0.000396	0.00122	CcSEcCtD
Docetaxel—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000396	0.00122	CcSEcCtD
Docetaxel—Myocardial infarction—Prednisone—Crohn's disease	0.000394	0.00121	CcSEcCtD
Docetaxel—Neuropathy peripheral—Prednisone—Crohn's disease	0.000394	0.00121	CcSEcCtD
Docetaxel—Hypersensitivity—Azathioprine—Crohn's disease	0.000392	0.0012	CcSEcCtD
Docetaxel—Abdominal pain—Mesalazine—Crohn's disease	0.000383	0.00118	CcSEcCtD
Docetaxel—Body temperature increased—Mesalazine—Crohn's disease	0.000383	0.00118	CcSEcCtD
Docetaxel—Diarrhoea—Azathioprine—Crohn's disease	0.000364	0.00112	CcSEcCtD
Docetaxel—Haemoglobin—Prednisone—Crohn's disease	0.000362	0.00111	CcSEcCtD
Docetaxel—Haemorrhage—Prednisone—Crohn's disease	0.00036	0.00111	CcSEcCtD
Docetaxel—Hypersensitivity—Mesalazine—Crohn's disease	0.000357	0.0011	CcSEcCtD
Docetaxel—Connective tissue disorder—Prednisone—Crohn's disease	0.000354	0.00109	CcSEcCtD
Docetaxel—Dizziness—Azathioprine—Crohn's disease	0.000351	0.00108	CcSEcCtD
Docetaxel—Asthenia—Mesalazine—Crohn's disease	0.000347	0.00107	CcSEcCtD
Docetaxel—Pruritus—Mesalazine—Crohn's disease	0.000342	0.00105	CcSEcCtD
Docetaxel—Vomiting—Azathioprine—Crohn's disease	0.000338	0.00104	CcSEcCtD
Docetaxel—Eye disorder—Prednisone—Crohn's disease	0.000337	0.00104	CcSEcCtD
Docetaxel—Rash—Azathioprine—Crohn's disease	0.000335	0.00103	CcSEcCtD
Docetaxel—Dermatitis—Azathioprine—Crohn's disease	0.000335	0.00103	CcSEcCtD
Docetaxel—Flushing—Prednisone—Crohn's disease	0.000335	0.00103	CcSEcCtD
Docetaxel—Headache—Azathioprine—Crohn's disease	0.000333	0.00102	CcSEcCtD
Docetaxel—Diarrhoea—Mesalazine—Crohn's disease	0.000331	0.00102	CcSEcCtD
Docetaxel—Angiopathy—Prednisone—Crohn's disease	0.000327	0.001	CcSEcCtD
Docetaxel—Immune system disorder—Prednisone—Crohn's disease	0.000326	0.001	CcSEcCtD
Docetaxel—Arrhythmia—Prednisone—Crohn's disease	0.000322	0.000989	CcSEcCtD
Docetaxel—Dizziness—Mesalazine—Crohn's disease	0.00032	0.000984	CcSEcCtD
Docetaxel—Alopecia—Prednisone—Crohn's disease	0.000319	0.000979	CcSEcCtD
Docetaxel—Mental disorder—Prednisone—Crohn's disease	0.000316	0.00097	CcSEcCtD
Docetaxel—Nausea—Azathioprine—Crohn's disease	0.000316	0.00097	CcSEcCtD
Docetaxel—Malnutrition—Prednisone—Crohn's disease	0.000314	0.000964	CcSEcCtD
Docetaxel—Erythema—Prednisone—Crohn's disease	0.000314	0.000964	CcSEcCtD
Docetaxel—Vomiting—Mesalazine—Crohn's disease	0.000308	0.000946	CcSEcCtD
Docetaxel—Rash—Mesalazine—Crohn's disease	0.000305	0.000938	CcSEcCtD
Docetaxel—Dermatitis—Mesalazine—Crohn's disease	0.000305	0.000937	CcSEcCtD
Docetaxel—Headache—Mesalazine—Crohn's disease	0.000303	0.000932	CcSEcCtD
Docetaxel—Anaemia—Prednisone—Crohn's disease	0.00029	0.000891	CcSEcCtD
Docetaxel—Nausea—Mesalazine—Crohn's disease	0.000288	0.000883	CcSEcCtD
Docetaxel—Syncope—Prednisone—Crohn's disease	0.000281	0.000865	CcSEcCtD
Docetaxel—Loss of consciousness—Prednisone—Crohn's disease	0.000276	0.000847	CcSEcCtD
Docetaxel—Convulsion—Prednisone—Crohn's disease	0.000272	0.000835	CcSEcCtD
Docetaxel—Hypertension—Prednisone—Crohn's disease	0.000271	0.000832	CcSEcCtD
Docetaxel—Arthralgia—Prednisone—Crohn's disease	0.000267	0.000821	CcSEcCtD
Docetaxel—Myalgia—Prednisone—Crohn's disease	0.000267	0.000821	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000265	0.000815	CcSEcCtD
Docetaxel—Oedema—Prednisone—Crohn's disease	0.000256	0.000787	CcSEcCtD
Docetaxel—Anaphylactic shock—Prednisone—Crohn's disease	0.000256	0.000787	CcSEcCtD
Docetaxel—Infection—Prednisone—Crohn's disease	0.000254	0.000782	CcSEcCtD
Docetaxel—Shock—Prednisone—Crohn's disease	0.000252	0.000774	CcSEcCtD
Docetaxel—ABCB1—lymph node—Crohn's disease	0.000252	0.00159	CbGeAlD
Docetaxel—Nervous system disorder—Prednisone—Crohn's disease	0.000251	0.000772	CcSEcCtD
Docetaxel—Tachycardia—Prednisone—Crohn's disease	0.00025	0.000768	CcSEcCtD
Docetaxel—Skin disorder—Prednisone—Crohn's disease	0.000249	0.000764	CcSEcCtD
Docetaxel—Anorexia—Prednisone—Crohn's disease	0.000244	0.00075	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000233	0.000717	CcSEcCtD
Docetaxel—Insomnia—Prednisone—Crohn's disease	0.000232	0.000712	CcSEcCtD
Docetaxel—Paraesthesia—Prednisone—Crohn's disease	0.00023	0.000707	CcSEcCtD
Docetaxel—Dyspepsia—Prednisone—Crohn's disease	0.000225	0.000693	CcSEcCtD
Docetaxel—Decreased appetite—Prednisone—Crohn's disease	0.000223	0.000684	CcSEcCtD
Docetaxel—Fatigue—Prednisone—Crohn's disease	0.000221	0.000678	CcSEcCtD
Docetaxel—Constipation—Prednisone—Crohn's disease	0.000219	0.000673	CcSEcCtD
Docetaxel—Feeling abnormal—Prednisone—Crohn's disease	0.000211	0.000648	CcSEcCtD
Docetaxel—Gastrointestinal pain—Prednisone—Crohn's disease	0.000209	0.000643	CcSEcCtD
Docetaxel—Abdominal pain—Prednisone—Crohn's disease	0.000202	0.000622	CcSEcCtD
Docetaxel—Body temperature increased—Prednisone—Crohn's disease	0.000202	0.000622	CcSEcCtD
Docetaxel—Hypersensitivity—Prednisone—Crohn's disease	0.000189	0.00058	CcSEcCtD
Docetaxel—Asthenia—Prednisone—Crohn's disease	0.000184	0.000565	CcSEcCtD
Docetaxel—Pruritus—Prednisone—Crohn's disease	0.000181	0.000557	CcSEcCtD
Docetaxel—Diarrhoea—Prednisone—Crohn's disease	0.000175	0.000538	CcSEcCtD
Docetaxel—Dizziness—Prednisone—Crohn's disease	0.000169	0.00052	CcSEcCtD
Docetaxel—Vomiting—Prednisone—Crohn's disease	0.000163	0.0005	CcSEcCtD
Docetaxel—Rash—Prednisone—Crohn's disease	0.000161	0.000496	CcSEcCtD
Docetaxel—Dermatitis—Prednisone—Crohn's disease	0.000161	0.000496	CcSEcCtD
Docetaxel—Headache—Prednisone—Crohn's disease	0.00016	0.000493	CcSEcCtD
Docetaxel—Nausea—Prednisone—Crohn's disease	0.000152	0.000467	CcSEcCtD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—JAK2—Crohn's disease	7.25e-05	0.000339	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	7.25e-05	0.000339	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—TLR4—Crohn's disease	7.24e-05	0.000339	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—STAT3—Crohn's disease	7.21e-05	0.000337	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TNF—Crohn's disease	7.19e-05	0.000336	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	7.19e-05	0.000336	CbGpPWpGaD
Docetaxel—EGFR—Disease—LTF—Crohn's disease	7.17e-05	0.000335	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—UBE2D1—Crohn's disease	7.14e-05	0.000334	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTMR3—Crohn's disease	7.05e-05	0.00033	CbGpPWpGaD
Docetaxel—BCL2—Immune System—UBE2D1—Crohn's disease	7.04e-05	0.000329	CbGpPWpGaD
Docetaxel—TUBB3—Transmembrane transport of small molecules—ALB—Crohn's disease	7.03e-05	0.000329	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	7.01e-05	0.000328	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—RIPK2—Crohn's disease	6.93e-05	0.000324	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TYK2—Crohn's disease	6.91e-05	0.000323	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL1B—Crohn's disease	6.9e-05	0.000323	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—UBE2D1—Crohn's disease	6.86e-05	0.000321	CbGpPWpGaD
Docetaxel—BCL2—Immune System—RIPK2—Crohn's disease	6.82e-05	0.000319	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ITGA4—Crohn's disease	6.82e-05	0.000319	CbGpPWpGaD
Docetaxel—TUBB2A—Transmembrane transport of small molecules—ALB—Crohn's disease	6.8e-05	0.000318	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TAGAP—Crohn's disease	6.76e-05	0.000316	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL3—Crohn's disease	6.66e-05	0.000311	CbGpPWpGaD
Docetaxel—TUBB1—Transmembrane transport of small molecules—ALB—Crohn's disease	6.65e-05	0.000311	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RIPK2—Crohn's disease	6.65e-05	0.000311	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ITGA4—Crohn's disease	6.65e-05	0.000311	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—JAK2—Crohn's disease	6.59e-05	0.000308	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—RASGRP1—Crohn's disease	6.53e-05	0.000306	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—STAT3—Crohn's disease	6.48e-05	0.000303	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	6.45e-05	0.000302	CbGpPWpGaD
Docetaxel—BCL2—Immune System—RASGRP1—Crohn's disease	6.44e-05	0.000301	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD79A—Crohn's disease	6.42e-05	0.0003	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTMR3—Crohn's disease	6.41e-05	0.0003	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TAB1—Crohn's disease	6.39e-05	0.000299	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTMR3—Crohn's disease	6.36e-05	0.000297	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TAB1—Crohn's disease	6.3e-05	0.000295	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NOD2—Crohn's disease	6.28e-05	0.000294	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RASGRP1—Crohn's disease	6.27e-05	0.000293	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD79A—Crohn's disease	6.25e-05	0.000292	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NOD2—Crohn's disease	6.19e-05	0.000289	CbGpPWpGaD
Docetaxel—KIF11—Immune System—IL6—Crohn's disease	6.15e-05	0.000288	CbGpPWpGaD
Docetaxel—ABCC1—Disease—GCKR—Crohn's disease	6.13e-05	0.000287	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CXCL8—Crohn's disease	6.02e-05	0.000281	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—STAT3—Crohn's disease	6.01e-05	0.000281	CbGpPWpGaD
Docetaxel—TUBB4A—Transmembrane transport of small molecules—ALB—Crohn's disease	5.97e-05	0.000279	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—SOCS1—Crohn's disease	5.92e-05	0.000277	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RSPO3—Crohn's disease	5.91e-05	0.000276	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—STAT3—Crohn's disease	5.88e-05	0.000275	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—TYK2—Crohn's disease	5.85e-05	0.000273	CbGpPWpGaD
Docetaxel—BCL2—Immune System—SOCS1—Crohn's disease	5.83e-05	0.000273	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—IL6—Crohn's disease	5.8e-05	0.000271	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—SMAD3—Crohn's disease	5.79e-05	0.000271	CbGpPWpGaD
Docetaxel—EGFR—Disease—GCKR—Crohn's disease	5.78e-05	0.00027	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NOD1—Crohn's disease	5.78e-05	0.00027	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCR6—Crohn's disease	5.74e-05	0.000269	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—IL6—Crohn's disease	5.72e-05	0.000268	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—SOCS1—Crohn's disease	5.68e-05	0.000266	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—FADS1—Crohn's disease	5.68e-05	0.000266	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—TYK2—Crohn's disease	5.64e-05	0.000264	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CXCL8—Crohn's disease	5.61e-05	0.000262	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CXCL8—Crohn's disease	5.61e-05	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SEL1L—Crohn's disease	5.6e-05	0.000262	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—JAK2—Crohn's disease	5.58e-05	0.000261	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—FADS1—Crohn's disease	5.49e-05	0.000257	CbGpPWpGaD
Docetaxel—TUBB4B—Transmembrane transport of small molecules—ALB—Crohn's disease	5.46e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TNF—Crohn's disease	5.42e-05	0.000254	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SLC11A1—Crohn's disease	5.42e-05	0.000254	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CXCL8—Crohn's disease	5.42e-05	0.000253	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	5.41e-05	0.000253	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—JAK2—Crohn's disease	5.38e-05	0.000252	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	5.32e-05	0.000249	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GPX4—Crohn's disease	5.32e-05	0.000249	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—TYK2—Crohn's disease	5.29e-05	0.000247	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL18—Crohn's disease	5.25e-05	0.000246	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CCR6—Crohn's disease	5.25e-05	0.000245	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CXCL8—Crohn's disease	5.25e-05	0.000245	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.22e-05	0.000244	CbGpPWpGaD
Docetaxel—SLC22A7—Transmembrane transport of small molecules—ALB—Crohn's disease	5.2e-05	0.000243	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.19e-05	0.000243	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GPX4—Crohn's disease	5.14e-05	0.000241	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GCKR—Crohn's disease	5.14e-05	0.00024	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CXCL8—Crohn's disease	5.13e-05	0.00024	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR9—Crohn's disease	5.12e-05	0.000239	CbGpPWpGaD
Docetaxel—EGFR—Disease—SLC11A1—Crohn's disease	5.11e-05	0.000239	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CD4—Crohn's disease	5.1e-05	0.000239	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PTGER4—Crohn's disease	5.06e-05	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—JAK2—Crohn's disease	5.05e-05	0.000236	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—Crohn's disease	5.03e-05	0.000235	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—Crohn's disease	5e-05	0.000234	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—FADS1—Crohn's disease	5e-05	0.000234	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GCKR—Crohn's disease	4.97e-05	0.000232	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—FADS1—Crohn's disease	4.95e-05	0.000232	CbGpPWpGaD
Docetaxel—SLCO1B3—Transmembrane transport of small molecules—ALB—Crohn's disease	4.94e-05	0.000231	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	4.89e-05	0.000229	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—STAT3—Crohn's disease	4.84e-05	0.000226	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—Crohn's disease	4.82e-05	0.000225	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PTPN2—Crohn's disease	4.8e-05	0.000224	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GPR65—Crohn's disease	4.76e-05	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RBX1—Crohn's disease	4.75e-05	0.000222	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—Crohn's disease	4.74e-05	0.000222	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GPX4—Crohn's disease	4.68e-05	0.000219	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2RA—Crohn's disease	4.66e-05	0.000218	CbGpPWpGaD
Docetaxel—ABCC1—Disease—RBX1—Crohn's disease	4.65e-05	0.000217	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HSPA1B—Crohn's disease	4.65e-05	0.000217	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GPX4—Crohn's disease	4.64e-05	0.000217	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.61e-05	0.000216	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CXCL8—Crohn's disease	4.61e-05	0.000215	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTMR3—Crohn's disease	4.6e-05	0.000215	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.54e-05	0.000212	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—Crohn's disease	4.53e-05	0.000212	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GCKR—Crohn's disease	4.52e-05	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—Crohn's disease	4.5e-05	0.000211	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—Crohn's disease	4.48e-05	0.00021	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GCKR—Crohn's disease	4.48e-05	0.00021	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CRP—Crohn's disease	4.46e-05	0.000209	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—Crohn's disease	4.46e-05	0.000209	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CRP—Crohn's disease	4.4e-05	0.000206	CbGpPWpGaD
Docetaxel—EGFR—Disease—RBX1—Crohn's disease	4.38e-05	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Disease—HSPA1B—Crohn's disease	4.38e-05	0.000205	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL3—Crohn's disease	4.31e-05	0.000201	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR4—Crohn's disease	4.28e-05	0.0002	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR4—Crohn's disease	4.22e-05	0.000197	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CXCL8—Crohn's disease	4.21e-05	0.000197	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—Crohn's disease	4.2e-05	0.000196	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—Crohn's disease	4.2e-05	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—Crohn's disease	4.2e-05	0.000196	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—RASGRP1—Crohn's disease	4.16e-05	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Immune System—UBE2D1—Crohn's disease	4.16e-05	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—Crohn's disease	4.16e-05	0.000195	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—Crohn's disease	4.12e-05	0.000193	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—Crohn's disease	4.1e-05	0.000192	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—STAT3—Crohn's disease	4.09e-05	0.000191	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PLA2G4F—Crohn's disease	4.08e-05	0.000191	CbGpPWpGaD
Docetaxel—ABCC1—Disease—UBE2D1—Crohn's disease	4.08e-05	0.000191	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ICAM1—Crohn's disease	4.04e-05	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ITGA4—Crohn's disease	4.03e-05	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RIPK2—Crohn's disease	4.03e-05	0.000189	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ICAM1—Crohn's disease	3.94e-05	0.000184	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL3—Crohn's disease	3.93e-05	0.000184	CbGpPWpGaD
Docetaxel—EGFR—Disease—UBE2D1—Crohn's disease	3.84e-05	0.00018	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RASGRP1—Crohn's disease	3.81e-05	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD79A—Crohn's disease	3.79e-05	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TYK2—Crohn's disease	3.78e-05	0.000177	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TAB1—Crohn's disease	3.72e-05	0.000174	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	3.72e-05	0.000174	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.67e-05	0.000172	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.66e-05	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NOD2—Crohn's disease	3.66e-05	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—JAK2—Crohn's disease	3.6e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	3.59e-05	0.000168	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—FADS1—Crohn's disease	3.58e-05	0.000167	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.55e-05	0.000166	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.53e-05	0.000165	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ALB—Crohn's disease	3.49e-05	0.000163	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTMR3—Crohn's disease	3.47e-05	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SOCS1—Crohn's disease	3.45e-05	0.000161	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR6—Crohn's disease	3.39e-05	0.000159	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—Crohn's disease	3.38e-05	0.000158	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX4—Crohn's disease	3.35e-05	0.000157	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TYK2—Crohn's disease	3.33e-05	0.000156	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TYK2—Crohn's disease	3.28e-05	0.000154	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GCKR—Crohn's disease	3.24e-05	0.000151	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.21e-05	0.00015	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—JAK2—Crohn's disease	3.18e-05	0.000149	CbGpPWpGaD
Docetaxel—BCL2—Immune System—JAK2—Crohn's disease	3.13e-05	0.000147	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.11e-05	0.000145	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL18—Crohn's disease	3.1e-05	0.000145	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IFNG—Crohn's disease	3.08e-05	0.000144	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.07e-05	0.000144	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RBX1—Crohn's disease	3.07e-05	0.000143	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2RA—Crohn's disease	3.02e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CD4—Crohn's disease	3.02e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTGER4—Crohn's disease	2.99e-05	0.00014	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CD4—Crohn's disease	2.97e-05	0.000139	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SMAD3—Crohn's disease	2.92e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—CD4—Crohn's disease	2.9e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—Crohn's disease	2.86e-05	0.000134	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—Crohn's disease	2.76e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2RA—Crohn's disease	2.76e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Disease—SMAD3—Crohn's disease	2.75e-05	0.000129	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—Crohn's disease	2.74e-05	0.000128	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—FADS1—Crohn's disease	2.7e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—UBE2D1—Crohn's disease	2.69e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—Crohn's disease	2.64e-05	0.000124	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RIPK2—Crohn's disease	2.61e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—Crohn's disease	2.6e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—Crohn's disease	2.59e-05	0.000121	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL3—Crohn's disease	2.54e-05	0.000119	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX4—Crohn's disease	2.53e-05	0.000118	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.51e-05	0.000118	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—Crohn's disease	2.49e-05	0.000117	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.47e-05	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RASGRP1—Crohn's disease	2.46e-05	0.000115	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GCKR—Crohn's disease	2.44e-05	0.000114	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ICAM1—Crohn's disease	2.39e-05	0.000112	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—Crohn's disease	2.31e-05	0.000108	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—Crohn's disease	2.3e-05	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—Crohn's disease	2.29e-05	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SOCS1—Crohn's disease	2.23e-05	0.000104	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTMR3—Crohn's disease	2.14e-05	9.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TYK2—Crohn's disease	2.13e-05	9.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—JAK2—Crohn's disease	2.03e-05	9.48e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—Crohn's disease	2.02e-05	9.46e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TYK2—Crohn's disease	1.94e-05	9.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMAD3—Crohn's disease	1.92e-05	9e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TYK2—Crohn's disease	1.9e-05	8.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—JAK2—Crohn's disease	1.85e-05	8.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—Crohn's disease	1.85e-05	8.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—Crohn's disease	1.85e-05	8.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IFNG—Crohn's disease	1.82e-05	8.5e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—JAK2—Crohn's disease	1.81e-05	8.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TYK2—Crohn's disease	1.79e-05	8.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2RA—Crohn's disease	1.78e-05	8.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD4—Crohn's disease	1.76e-05	8.21e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CD4—Crohn's disease	1.72e-05	8.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—JAK2—Crohn's disease	1.71e-05	8e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—Crohn's disease	1.71e-05	7.99e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FADS1—Crohn's disease	1.66e-05	7.79e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.66e-05	7.77e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—Crohn's disease	1.63e-05	7.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—Crohn's disease	1.63e-05	7.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—Crohn's disease	1.62e-05	7.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CD4—Crohn's disease	1.62e-05	7.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—Crohn's disease	1.61e-05	7.53e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—Crohn's disease	1.61e-05	7.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—Crohn's disease	1.58e-05	7.39e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX4—Crohn's disease	1.56e-05	7.29e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCKR—Crohn's disease	1.51e-05	7.04e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—Crohn's disease	1.44e-05	6.73e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—Crohn's disease	1.43e-05	6.69e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—Crohn's disease	1.43e-05	6.67e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—Crohn's disease	1.38e-05	6.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—Crohn's disease	1.36e-05	6.36e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—Crohn's disease	1.33e-05	6.23e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—Crohn's disease	1.26e-05	5.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TYK2—Crohn's disease	1.26e-05	5.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—Crohn's disease	1.26e-05	5.87e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.25e-05	5.83e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—JAK2—Crohn's disease	1.2e-05	5.6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—Crohn's disease	1.09e-05	5.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—Crohn's disease	1.04e-05	4.86e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—Crohn's disease	1.03e-05	4.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—Crohn's disease	9.5e-06	4.44e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—Crohn's disease	9.3e-06	4.35e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—Crohn's disease	9.02e-06	4.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—Crohn's disease	8.79e-06	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—Crohn's disease	8.77e-06	4.1e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—Crohn's disease	7.78e-06	3.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—Crohn's disease	6.8e-06	3.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—Crohn's disease	6.14e-06	2.87e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—Crohn's disease	4.79e-06	2.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—Crohn's disease	4.19e-06	1.96e-05	CbGpPWpGaD
